Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Beyond Progression in HR+ Breast Cancer
NCT02269670Phase 2Terminated
- Sponsor
- Emory University
- Start
- Nov 2014
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Emory University. Started Nov 2014; status: terminated.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02269670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269670.